Liang Liang,Zhang Yinbin,Zan Ying,et al.. Implication of miR-139 in hepatocellular carcinoma and bioinformatics analysis of its perimentally validated targets genes[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(5): 554-558.
[1] Torre LA,Bray F,Siegel RL,et al. Global cancer statistics,2012. Ca Cancer J Clin,2015,65(2):87-108. [2] 张杰,段伯焕,朱功兵. 肝细胞癌患者外科手术根治术后生存分析. 实用肝脏病杂志,2017,20(1):93-96. [3] Hao M,Zang M,Zhao M,et al. Serum high expression of mir-214 and mir-135b as novel predictor for myeloma bone disease development and prognosis. Oncotarget,2016,7(15):19589-19600. [4] 郝清亚,王以浪,姚登福,等. 肝癌患者血清microRNA-21水平变化. 实用肝脏病杂志,2014,17(1):68-70. [5] Cai L,Cai X. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma. Diagnost Pathol,2014,9:1000. [6] Wang Z,Yang H,Ren H. MiR-21 promoted proliferation and migration in hepatocellular carcinoma through negative regulation of navigator-3. Biochem Biophys Res Commun,2015,464(4):1228-1234. [7] Qiu G,Lin Y,Zhang H,et al. MiR-139-5p inhibits epithelial-mesenchymal transition,migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.Biochem Biophys Res Commun,2015,463(3):315-321. [8] 裴丽玲,李建生,任维华. miRNAs与肝细胞癌发生研究进展. 实用肝脏病杂志,2014,17(2):221-224. [9] Fan Q,He M,Deng X,et al. Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma. Cell Biochem Funct,2013,31(4):319-324. [10] Gu W,Li X,Wang J. MiR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway. Oncol Rep,2014,31(1):397-404. [11] Wong CCL,Wong CM,Tung EKK,et al. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology,2011,140(1):322-331. [12] Chou CH,Chang NW,Shrestha S,et al. miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database.Nucleic Acids Res,2016,44(1):239-247. [13] 杨秀珍,耿爱文,肖丽,等. 慢性乙型肝炎合并脂肪肝临床与肝组织病理学分析. 实用肝脏病杂志,2017,20(1):101-102. [14] Goodman ZD. Neoplasms of the liver.Mod Pathol,2007,20(1):49-60. [15] Bartel DP. MicroRNAs:genomics,biogenesis,mechanism,and fun- ction. Cell,2004,v116(2):281-297. [16] MacFarlane LA,Murphy PR. MicroRNA:Biogenesis,function and role in cancer. Curr Genomics,2015,11(7):537-561. [17] Maoa R,Zou F,Yang L,et al.The loss of miR-139-5p promotes colitis-associated tumorigenesis by mediating PI3K/AKT/Wnt signaling. Int J Biochem Cell Biol,2015,69:153-161. [18] Wang H,Yan X,Ji LY,et al. MiR-139 functions as an antioncomir to repress glioma progression through targeting IGF-1 R,AMY-1,and PGC-1β. Technol Cancer Res Treat,2016[ahead of print]. [19] Zou F,Mao R,Yang S,et al. Targeted deletion of miR-139-5p activates MAPK,NF-κB and STAT3 signaling and promotes intestinal inflammation and colorectal cancer. FEBS J,2016,283(8):1438-1452. [20] Wang X,Wang X. Systematic identification of microRNA functions by combining target prediction and expression profiling. Nucl Acid Res,2006,34(5):1646-1652.